Clinical Trial Update: Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs

View source ↗

Summary

This trial update reports quality-of-life outcomes for Humira (adalimumab) in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis, Ankylosing Spondylitis | Status: COMPLETED | Results posted: 2011-07-26